Use a Checklist to Help Patients Safely use DOACs

October 2015

We're getting questions about how to monitor patients on direct oral anticoagulants...Pradaxa, Xarelto, Eliquis, and Savaysa.

We know these "DOACs" (Direct Oral AntiCoagulants) don't have good lab tests to assess efficacy and bleeding risk...like INR with warfarin.

But they still need clinical monitoring to ensure appropriate use.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Women's Health Look Forward to Prescribing Hormonal Contraceptives
Anticoagulants Use a Checklist to Help Patients Safely use DOACs
Cardiology Help Patients Stick With a Statin...Instead of the New PCSK9 Inhibitors
Oral Health Don't Recommend Antibiotics Before Dental Work for Prosthetic Joint Patients
Testosterone Educate Men About Risks of Testosterone for "Low T"
Vaccines Explain that Bexsero and Trumenba Only Protect Against Meningitis B
Substance Use Disorder Be Alert to Unexpected Drugs of Abuse...Such as Bupropion
Diabetes Listen for Gliptin Patients Complaining of Severe Joint Pain
Biosimilars Explain That Biosimilars are not Exact Generic Equivalents
HIV & AIDS Recommend Avoiding Some HIV Drugs With Simvastatin or Lovastatin
Sexual Dysfunction Explain Why Addyi ISN'T a Good Choice for Sexual Dysfunction in Women
Interactions Watch for Hypoglycemia in Patients Taking Repaglinide Plus Clopidogrel